NM_144596.4:c.2T>C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PVS1_SupportingPM2
The NM_144596.4(TTC8):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000619 in 1,454,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144596.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000858 AC: 2AN: 232976Hom.: 0 AF XY: 0.00000785 AC XY: 1AN XY: 127434
GnomAD4 exome AF: 0.00000619 AC: 9AN: 1454278Hom.: 0 Cov.: 31 AF XY: 0.00000553 AC XY: 4AN XY: 722790
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 8;C3150715:Retinitis pigmentosa 51 Uncertain:1
- -
Bardet-Biedl syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals with TTC8-related conditions. This variant is present in population databases (rs776086794, ExAC 0.03%). This sequence change affects the initiator methionine of the TTC8 mRNA. The next in-frame methionine is located at codon 5. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at